Active-ingredient Dossier
Deferasirox
Active-ingredient Dossier for Deferasirox (iron chelator). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: Deferasirox Juno
- Brand: JADENU
- Brand: Deferasirox
- Brand: DEFERASIROX-TEVA
- Brand: EFERAS
- Brand: CHEALAC
- Therapeutic area: Haematology
What is
Deferasirox Deferasirox is an iron chelator.
Australian brands containing
Deferasirox — Deferasirox Juno — JADENU — DEFERASIROX FCT MSN — Deferasirox — DEFERASIROX-TEVA — EFERAS
Therapeutic areas
Deferasirox is registered in haematology, with 12 brands containing the ingredient on the ARTG.
Sponsor landscape
The ingredient is marketed by 10 sponsors including Cipla, Medsurge Pharma, Alembic Pharmaceuticals, Sandoz, Accelagen and Juno Pharmaceuticals.
PBS and regulatory activity
Two brands containing deferasirox have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2020.